From: Radiotherapy refusal in breast cancer with breast-conserving surgery
Radiotherapy performed | Radiotherapy refused | P-value | |||
---|---|---|---|---|---|
No | % | No | % | ||
Years at diagnosis | |||||
2010 | 12,247 | 14.40 | 261 | 12.10 | < 0.001 |
2011 | 13,254 | 15.60 | 283 | 13.20 | |
2012 | 13,577 | 16.00 | 359 | 16.70 | |
2013 | 14,048 | 16.50 | 321 | 14.90 | |
2014 | 15,284 | 18.00 | 391 | 18.20 | |
2015 | 16,538 | 19.50 | 537 | 25.00 | |
Age | |||||
≤ 50 | 17,165 | 20.20 | 211 | 9.80 | < 0.001 |
> 50 | 67,783 | 79.80 | 1941 | 90.20 | |
Income | |||||
< 65,000 | 40,684 | 47.90 | 1328 | 61.70 | < 0.001 |
≥ 65,000 | 44,264 | 52.10 | 824 | 38.30 | |
Marital | |||||
Married | 52,983 | 62.40 | 974 | 45.30 | < 0.001 |
Single | 12,068 | 14.20 | 291 | 13.50 | |
Divorced | 19,897 | 23.40 | 887 | 41.20 | |
Race | |||||
White | 69,215 | 81.50 | 1860 | 86.40 | < 0.001 |
Black | 7855 | 9.20 | 170 | 7.90 | |
Others | 7878 | 9.30 | 122 | 5.70 | |
Grade | |||||
Grade I + II | 62,435 | 73.50 | 1660 | 77.10 | < 0.001 |
Grade III + IV | 22,513 | 26.50 | 492 | 22.90 | |
Stage | |||||
Stage I | 54,636 | 64.30 | 1479 | 68.70 | < 0.001 |
Stage II | 27,056 | 31.90 | 605 | 28.10 | |
Stage III | 3256 | 3.80 | 68 | 3.20 | |
T stage | |||||
T1 | 63,396 | 74.60 | 1611 | 74.90 | < 0.001 |
T2 | 19,922 | 23.50 | 491 | 22.80 | |
T3 | 1335 | 1.60 | 29 | 1.30 | |
T4 | 295 | 0.30 | 21 | 1.00 | |
N stage | |||||
N0 | 67,975 | 80.00 | 1870 | 86.90 | < 0.001 |
N1 | 14,419 | 17.00 | 238 | 11.10 | |
N2 | 1893 | 2.20 | 29 | 1.30 | |
N3 | 661 | 0.80 | 15 | 0.70 | |
ER status | |||||
Negative | 11,098 | 13.10 | 208 | 9.70 | < 0.001 |
Positive | 73,850 | 86.90 | 1944 | 90.30 | |
PR status | |||||
Negative | 18,823 | 22.20 | 396 | 18.40 | < 0.001 |
Positive | 66,125 | 77.80 | 1756 | 81.60 | |
HER-2 status | |||||
Negative | 75,448 | 88.80 | 1955 | 90.80 | 0.003 |
Positive | 9500 | 11.20 | 197 | 9.20 | |
Subtype | |||||
HR + /HER-2 + | 7048 | 8.30 | 148 | 6.90 | < 0.001 |
HR + /HER-2- | 67,543 | 79.50 | 1809 | 84.10 | |
HR-/HER-2 + | 2452 | 2.90 | 49 | 2.30 | |
HR-/HER-2- | 7905 | 9.30 | 146 | 6.80 | |
Chemotherapy | |||||
No | 55,663 | 65.50 | 1964 | 91.30 | < 0.001 |
Yes | 29,285 | 34.50 | 188 | 8.70 |